Inventor · disambiguated record

Roland Knoblauch

Also filed as: KNOBLAUCH ROLAND

2 granted patents·9 pending applications·1 citations·filing 2010–2025

30Inventor score

Technology areasC07K A61K A61P G01N

Files withJANSSEN BIOTECH INC10 THOMPSON CRAIG B1

Top patents by PatentIndex Score

11 records

0167US8574829B2Methods of treating cancer with phenforminTHOMPSON CRAIG B·Filed 2010·Granted Nov 5, 2013·1 cites·16 claims
0257US2024368310A1Use of approved bispecific egfr and met specific antibody drug product to treat non-small cell lung cancerJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
0356US2023174677A1Use of Approved Bispecific EGFR and Met Specific Antibody Drug Product to Treat Non-Small Cell Lung Cancer (NSCLCL)JANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
0454US2023183360A1Use of Amivantamab to Treat Colorectal CancerJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
0553US2022395573A1High Concentration Bispecific Antibody FormulationsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
0651US12215160B2Treatment of patients having c-met exon 14 skipping mutationsJANSSEN BIOTECH INC·Filed 2021·Granted Feb 4, 2025·0 cites·47 claims
0750US2025388681A2Dosing Regimen for Therapies Comprising Bispecific Anti-EGFR/C-Met AntibodesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
0850US2024034813A1High Concentration Bispecific Antibody FormulationsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
0949US2025195649A1High Concentration Bispecific Antibody FormulationsJANSSEN BIOTECH INC·Filed 2025·Application pending·0 cites
1048US2024317866A1Use of Anti-EGFR/Anti-Met Antibody to Treat Gastric or Esophageal CancerJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
1145US2025257139A1Use of Amivantamab to Treat Colorectal CancerJANSSEN BIOTECH INC·Filed 2025·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Roland Knoblauch files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →